Gemelli Biotech is a biotechnology company that supports the discovery of diagnostics and therapeutics for human microbiome. Its product offerings include ibs-smart, a blood test that measures the levels of antibodies known to be elevated in patients with post-infectious irritable bowel syndrome (IBS), and sclero-smart, a tool that measures the levels of anti-vinculin, an antibody that is elevated in patients with systemic sclerosis and scleroderma.